Alteration of superficial bacterial flora in severely ill patients: I.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001315:Australia; D001365:Axilla / Q000382:microbiology; D001419:Bacteria / Q000302:isolation & purification*; D002353:Carrier State; D004352:Drug Resistance, Microbial; D006760:Hospitalization; D006801:Humans; D009666:Nose / Q000382:microbiology*; D010405:Penicillinase / Q000378:metabolism; D010614:Pharynx / Q000382:microbiology*; D011511:Proteus / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012867:Skin / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects / Q000201:enzymology / Q000302:isolation & purification; D013997:Time Factors
D000900:Anti-Bacterial Agents; D010405:Penicillinase